Stability-indicating assay method for estimation of olmesartan medoxomil and its metabolite

Journal of Liquid Chromatography and Related Technologies

Volumn 32, Issue 10, 2009, Pages 1516-1526

  Trivedi, Piyush ^a   Kartikeyan, C ^a   Kachave, Raman ^a   Bhadane, Rajendra ^a  

^a UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

Author keywords

HPLC; LC MS MS; Olmesartan medoxomil; Stability indicating assay method

Indexed keywords

DEGRADATION PRODUCTS; HPLC; HPLC METHOD; ISOCRATIC; LC-MS/MS; LIQUID CHROMATOGRAPHIC ASSAY; MOBILE PHASE; OLMESARTAN MEDOXOMIL; PHOSPHATE BUFFERS; STABILITY INDICATING ASSAY METHOD; STABILITY-INDICATING ASSAYS; VALIDATION STUDY;

DEGRADATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; METHANOL; STABILITY;

DRUG PRODUCTS;

BUFFER; DRUG METABOLITE; METHANOL; OLMESARTAN;

ACCURACY; ARTICLE; CHEMICAL STRESS; DEGRADATION; DRUG DEGRADATION; DRUG DETERMINATION; DRUG ISOLATION; DRUG STABILITY; FLOW RATE; HEAT STRESS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; OXIDATION; PH; PHOTOLYSIS; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

EID: 70349484641     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070902901606     Document Type: Article

References (18)

1. Koike, H.; Konse, T.; Sada, T.; Ikeda, T.; Hyogo, A.; Hinman, D.; Saito, H.; Yanagisawa, H. Olmesartan medoxomil, a novel potent angiotensin II blocker. Annu. Rep. Sankyo Res. Lab. 2003, 55, 1-91.
2. The Merck Index, an encyclopedia of chemical drug and biologicals; Merck Research Laboratories, White House Station, NJ, 2001, 13 1223-1224.
3. Available from http://www.rxlist.com/cgi/generic/olmesatan.htm
4. ICH, Stability testing of new drug substances and products. International conference on harmonization. IFPMA, Geneva, 1993.
5. ICH, Impurities in new drug products. International conference on harmonization. IFPMA, Geneva, 1996.
6. ICH, Specifications: Test procedures and acceptance criteria for new drug substances and new drug products: chemical substances. International conference on harmonization. IFPMA, Geneva, 1999.
7. ICH, Quality of biotechnological products: stability testing of biotechnological/ biological products, international conference on harmonization. IFPMA, Geneva, 1995.
8. ICH, Stability testing of new drug substances and products Q1A (R2), international conference on harmonization. IFPMA, Geneva, 2003.
9. Singh, S.; Garg, S. Analytical method validation. Pharma Times, 1999, 15-20.
10. ICH, Text on validation of analytical procedures. International conference on harmonization of technical requirements for registration of pharmaceutical for human use. Geneva, 2000.
11. ICH, Stability Testing: Photostability testing of new drug substances and products international conference on harmonization. Geneva, November 1996.
12. Anderson, N.H. Photostability testing: Design and interpretation of tests on drug substances and dosage forms, Taylor and Francis: London, 1996.
13. Singh, S.; Bakshi, M. Guidance on conduct of stress tests to determine inherent stability of drugs pharm. Tech. 2000, 24, 1-14.
14. Hong, D.D.; Shah, M. Development and validation of HPLC stability-indicating assays. Drug stability: Principles and practices; Marcel Dekker: New York, 2000; 329-384.
15. Ragehy, N.A.; Abbas, S.S.; El-Khateeb, S.Z. Photodegradation studies on atenolol by liquid chromatography. J. Pharm. Biomed. Anal. 2001, 25, 143-151.
16. Lovdahl, M.J.; Priebe, S.R. Characterization of clinafloxacin photodegrada-tion products by LC-MS: MS and NMR, J. Pharm. Biomed. Anal. 2000, 15, 521-534.
17. Abdel-Hamid, M.; Novotny, L.; Hamza, H. Stability study of selected adeno-sine nucleosides using LC and LC: MS analyses. J. Pharm. Biomed. Anal. 2000, I, 745-755.
18. Bakshi, M.; Singh, S. ICH guidance in practice: Establishment of inherent stability of secnidazole and development of a validated stability indicating high performance liquid chromatographic assay method. J. Pharm. Biomed. Anal. 2004, 36(4), 769-775.